1. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet, 2003, 361(9367): 1411-1417.
2. Sant M, Allemani C, Berrino F, et al. Breast cancer survival in Europe and the United States. Cancer, 2004, 100(8): 715-722.
3. Olsen AH, Njor S, Vejborg W, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ, 2005, 330(5): 220-222.
4. Indraneel M, Michael B, Hazel T. Is clinical breast examination an acceptable alternative to mammographic screening? BMJ, 2000, 321(8): 1071-1073.
5. Elmore JG, Armstrong K, Lehman CD, et al. Screening for breast cancer. JAMA, 2005, 293(10): 1245-1256.
6. Irwig L, Houssami N, van-Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer, 2004, 90(11): 2118-2122.
7. Plaza CI. Health insurance issue brief: mandated benefits: breast cancer screening coverage requirements: year end report--2004. Issue Brief Health Policy Track Serv, 2004, 31(1):1-11.
8. Smith B. Physician Predictors of Mammographic Accuracy. J Natl Cancer Inst, 2005, 97(5): 358-367.
9. Rawal R, Lorenzo-Bermejo J, Hemminki K. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening. Br J Cancer, 2005, 92(1): 162-166.
10. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA, 2004, 292(11): 1317-1325.
11. Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg, 2004, 198(2): 190-197.
12. Hartman AR, Daniel BL, Kurian AW, et al. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. Cancer, 2004, 100(3): 479-489.
13. Calderon Margalit R, Paltiel O. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer, 2004, 112(3): 357-364.
14. Keogh LA, Southey MC, Maskiell J, et al. Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiol Biomarkers Prev, 2004, 13(12): 2258-2263.
15. Rogozinska-Szczepka J, Utracka-Hutka B, Grzybowska E, et al. BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Ann Oncol, 2004, 15(9): 1373-1376.
16. Ozanne EM, Esserman LJ. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev, 2004, 13(12): 2043-2052.
17. Hurria A, Leung D, Trainor K, et al. Screening chest imaging studies are not effective in the follow-up of breast cancer patients. J Oncol Manag, 2003, 12(5): 13-15.
18. CT Smith AP, Hall PA, Marcello DM. Emerging technologies in breast cancer detection. Radiol Manage, 2004, 26(4): 16-24.